Prelude Therapeutics Incorporated PRLD
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| Deerfield Mgmt, L.P. | Delaware | 0 | 3222690 | 0 | 0 | 3222690 | 7.68 % | 13/11/2023 |
| Deerfield Management Company, L.P. | Delaware | 0 | 3222690 | 0 | 0 | 3222690 | 7.68 % | 13/11/2023 |
| Deerfield Partners, L.P. | Delaware | 0 | 3222690 | 0 | 0 | 3222690 | 7.68 % | 13/11/2023 |
| James E. Flynn | United States | 0 | 3222690 | 0 | 0 | 3222690 | 7.68 % | 13/11/2023 |
| Management division of UBS Group AG (see Item 7) | Switzerland | 0 | 0 | 0 | 0 | 2507992 | 5.24 % | 13/02/2023 |
| Krishna Vaddi | 3618553 | 0 | 3618553 | 0 | 3618553 | 9.7 % | 04/02/2022 | |
| Krishna Vaddi | Delaware | 2937772 | 0 | 2937772 | 0 | 2937772 | 12.62 % | 11/02/2021 |
| Abigail P. Johnson | United States of America | 0 | 0 | 4209963 | 0 | 4209963 | 9.633 % | 08/02/2021 |
| FMR LLC | Delaware | 420438 | 0 | 4209963 | 0 | 4209963 | 9.633 % | 08/02/2021 |
| OrbiMed Capital LLC | Cayman Islands | 789500 | 0 | 789500 | 10 | 789500 | 1.8 % | 05/10/2020 |
| OrbiMed Advisors LLC | Delaware | 0 | 14805377 | 0 | 10 | 14805377 | 33.9 % | 05/10/2020 |
| OrbiMed Capital GP VI LLC | Delaware | 0 | 14805377 | 0 | 10 | 14805377 | 33.9 % | 05/10/2020 |
| Julian C. Baker | United States | 10121228 | 0 | 10121228 | 10 | 10121228 | 31.1 % | 30/09/2020 |
| Felix J. Baker | United States | 10121228 | 0 | 10121228 | 10 | 10121228 | 31.1 % | 30/09/2020 |
| Baker Bros. Advisors LP | Delaware | 10121228 | 0 | 10121228 | 10 | 10121228 | 31.1 % | 30/09/2020 |
| Baker Bros. Advisors (GP) LLC | Delaware | 10121228 | 0 | 10121228 | 10 | 10121228 | 31.1 % | 30/09/2020 |